Navigation Links
Don't Wait to Innovate: Future Pharmaceuticals Magazine Releases Its Issue on Innovation in IT, Cell-Based Therapy and Supply Chains
Date:9/9/2009

NEW YORK, Sept. 9 /PRNewswire/ -- Future Pharmaceuticals features an exclusive interview with Dave Champagne, Vice President and General Manager of Informatics at Thermo Fisher Scientific, and Thor-Gunnar Steinsli, LIMS Manager and Chief Engineer at HUNT Research Center and Biobank, about data integration: the benefits of data, instrument and enterprise integration strategies and challenges at life sciences companies.

"One of the biggest challenges facing life sciences companies has to do with managing the ever-growing volume of data and connecting all of the disparate sources of data throughout an organization," Champagne said.

"HUNT Biobank is a vivid example of the benefits of this type of integrated solution who helped us secure Microsoft's prestigious Pharmaceutical and Life Sciences Innovation Award in Discovery and Product Innovation (for more information visit http://www.thermo.com/informatics)," Champagne added.

The Director of Global Quality Labs at Eli Lilly, Jackie Larew, is featured in this issue leading an expert panel around issues facing the supply chain. One of the questions she poses to the panel is around the recent concerns we've seen with pet food and milk products tainted with melamine and contaminated heparin entering the U.S. supply chain. "What implications does this have for the way pharmaceutical companies ensure quality from their suppliers with an increasingly global supply chain of raw materials?" Larew asked the panelists.

This edition of FP also delves into the changing world of cell-based therapy. Mark Thiede, Research Fellow with Pfizer for the Genetically Modified Models Center of Emphasis, guest moderates a panel discussion on the future of the cellular therapy industry. Read the piece, Diagnosis: Cell-based Therapy
'/>"/>

SOURCE Future Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Boston University Periodontal Study on Imagenetix Compound Published in The Journal of Periodontology
2. Ondine Announces Presentation of Positive Clinical Trial Results at the American Academy of Periodontologys 94th Annual Meeting
3. Interleukin Genetics to Present at the 13th International Conference on Periodontal Research
4. Beike Biotech Adds International Executives to Strengthen Current Technologies and Develop Future Pipeline
5. California Life Science, Business, and Economic Development Experts Discuss Californias Bioscience Future
6. New nanolaser key to future optical computers and technologies
7. Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies
8. Industry Leaders Will Gather to Discuss the Future of the "Hydrogen Economy" in Washington DC
9. GreenHouse Energy, Governor Schwarzenegger Join in Driving the Future of Fueling in California
10. POET to Outline Cellulosic Ethanol's Present, Future at Brazil's Ethanol Summit 2009
11. Health Strategies Group Forecasts Emerging Trends in Future Sales Force Models at the SPBT 2009 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... The winners of awards for supply chain ... Global Supply Chain Resiliency Council (GSCRC) at ... February 25th, 2015, at the Hyatt Regency in Santa ... together supply chain risk management and resiliency practitioners with ... through opportunities to collaborate, develop and share best practices, ...
(Date:3/3/2015)... , March 3, 2015  RegeneRx Biopharmaceuticals, Inc. ... in the scientific journal, Expert Opinion on Biological ... colleague, Dr. Zhenggang Zhang , at the Henry ... reported that Thymosin beta 4 (TB4) has the capacity ... 24 hours or more post-injury, leading to neurological recovery ...
(Date:3/3/2015)... 2015  Rosa & Co. LLC, a drug development ... research, today announced it has two posters scheduled to ... Pharmacology and Therapeutics meeting in New Orleans, ... Logo - http://photos.prnewswire.com/prnh/20150302/179058LOGO   Bristol- ... describing a quantitative systems pharmacology approach for immuno-oncology drug ...
(Date:3/3/2015)... FRANCISCO , March 3, 2015 Kindred Biosciences, ... on saving and improving the lives of pets, announced today ... financial results on March 12, 2015 after the market close. ... Eastern Time that day. Interested parties may ... US, or (484) 756-4262 internationally, and using conference ID 98449349.  ...
Breaking Biology Technology:Global Supply Chain Resiliency Council Names Award Winners 2Global Supply Chain Resiliency Council Names Award Winners 3Global Supply Chain Resiliency Council Names Award Winners 4Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 2Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 3
... R-Tech Ueno, Ltd. announced on July 29 after discussing its R&D ... the day and determined the R&D items as follows. , ... the ophthalmologic & dermatological fields that are its priority and exclusive ... , 1. Development code UF-021 (eye diseases) , ...
... , , SAN DIEGO, July 30 ... the protocol for the Company,s Phase II trial of ANA598 in combination ... the protocol has been received from the United States Food and Drug ... several weeks. , , In the Phase II study, ...
... , , SEATTLE, July 30 Trubion ... to issue earnings results for its second quarter and six months ended ... The company,s earnings conference call will take place Aug. 6, 2009 at ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090320/TRUBIONLOGO ) , , The ...
Cached Biology Technology:R-Tech Ueno Notifies R&D Items 2R-Tech Ueno Notifies R&D Items 3Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients 2Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients 3Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients 4Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients 5Trubion Announces Dates for Second Quarter and First Half 2009 Earnings Conference Call 2
(Date:2/12/2015)... OXFORD, Conn. , Feb. 12, 2015 ... ("NXT-ID" or the "Company"), a biometric authentication company focused ... it has filed provisional patent 62/113114 for ... MULTIPLE DEVICES. The patent further establishes NXT-ID,s ... to its intellectual property portfolio the ability for multiple ...
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America ... methods for carbon nanotube (CNT) macrostructures, including sheets, yarns ... Dallas (UTD). Leveraging the vast industrial resources ... Tokyo, Japan , Lintec of America is forming ... Richardson, TX , focusing on scaling up the ...
(Date:2/5/2015)... DIEGO , Jan. 26, 2015   Epic Sciences ... of cancer, today announced that Murali Prahalad , Ph.D., ... Personalized Medicine World Conference (PMWC) 2015: Silicon Valley, which ... Mountain View, Calif. on January 26-28, 2015. ... "CTCs Come of Age as Biomarkers." Last year, Epic Sciences ...
Breaking Biology News(10 mins):NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2
... flowers have evolved particular colours, shapes and scents ... using artificial flowers and high-speed video, researchers have ... hummingbirds and the flowers they pollinate. The study, ... Functional Ecology , is the first to measure ...
... grey seal mums adopt risky tactics when it comes to the ... a real advantage, according to scientists. Researchers from Durham University, ... colonies in Scotland, found that some seal mothers are flexible in ... their actions, whilst other play it safe and steady. ...
... Calif.) When your neighbor asks to borrow a cup of ... of the give and take that characterize your longstanding relationship? Or ... of sugar you borrowed last week, or may need to borrow ... anthropology at UC Santa Barbara, and a junior research fellow at ...
Cached Biology News:High-speed video and artificial flowers shed light on mysteries of hummingbird-pollinated flowers 2Seals gamble with their pups' futures 2Seals gamble with their pups' futures 3UCSB anthropologist studies reciprocity among chimpanzees and bonobos 2UCSB anthropologist studies reciprocity among chimpanzees and bonobos 3
Chicken polyclonal to ytzF ( Abpromise for all tested applications). Antigen: Full length protein...
Fetal Calf Serum Replacement (Bistec) serum...
...
Mouse monoclonal [Ley 37D/G6] to LKB1 ( Abpromise for all tested applications). entrezGeneID: 6794 SwissProtID: Q15831...
Biology Products: